Skip to main content
Caplight Logo









Arthrone

Arthrone

Private
BeijingHealthcare & Life Scienceshttp://arthrone.com/

Last Round

Series C

Extension

Apr 3, 2026

Total Funding Raised

$49.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arthrone is a therapeutic devices company that develops and manufactures orthopaedic medical devices designed to restore joint function and treat musculoskeletal conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

orthopedic implantsceramic implantsjoint replacementbioceramic technologymedtechhip replacementzirconia femoral headknee replacementmedical device manufacturinghip arthroplastyspine implantsknee arthroplastytotal hip replacementTHRdental implantstotal knee replacementTKRNMPA approval

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arthrone Comparables

Compare Arthrone with similar companies based on industry and business-model similarity.

Arthrone comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AK Medical Holdings Ltd
83%
Just Medical Devices (Tianjin) Co., Ltd.
83%
Beijing Lidakang Technology Co., Ltd.
82%

Arthrone Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionApr 3, 2026
Series CAug 25, 2023
Series BMar 10, 2021
Series AMay 21, 2019
AngelSep 6, 2017

Arthrone Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Raised $21M led by Beijing E-Town International Investment.

  • Sep 6, 2017

    Completed an Angel funding round.

Arthrone Filings

Explore SEC and related filing metadata, where available.

Arthrone filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arthrone's valuation, stock price, and market status.

Is Arthrone a public or private company?

Arthrone is a private company.

What is the current stock price of Arthrone?

Arthrone is a private company with no public stock price. No recent secondary market data is available.

How much is Arthrone worth (valuation)?

Valuation information for Arthrone is not publicly available.

Can I buy Arthrone stock?

Arthrone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arthrone's last funding round?

Funding round information for Arthrone is not publicly available.

Who are the main investors in Arthrone?

Investor information for Arthrone is not publicly disclosed.

Will Arthrone IPO soon?

No public IPO plans have been announced for Arthrone.

How can I track Arthrone secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arthrone's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range1
Year Founded2017
Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?